Traders are eyeing Alibaba's IPO and Scotland's independence vote, but analysts said the Fed's dovishness statement could be more important.» Read More
Exact Sciences' CEO Kevin Conroy weighs in on the Medicare spending talks in Washington, and discusses his company's development of non-invasive ways to detect colorectal cancer.
Mad Money host Jim Cramer begins the annual stock Super Bowl by pitting the best performers in the Dow Jones average against each other.
NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.
Mad Money host Jim Cramer explains why it's important to find market themes that will withstand the test of circumstances surrounding the markets. "Themes are the quintessential non-risk on risk off investment that you can fall back on when the market sells off," he says.
The biggest predictions of 2013, including Procter & Gamble, Ford and Apple, with Doug Kass, president and founder of Seabreeze Partners. The Fast Money traders, weigh in.
The CDC says this is the most aggressive early flu season in 8 years. Discussing which under-the-weather trades could lead to some healthy profits, with the Fast Money traders; and Dan Hurwitz, DDR CEO, discusses the winners and losers in retail now, and what's next for DDR.
Matt Rubin, CIO, Neuberger Berman Trust advises investors to look at individual companies with attractive valuations and emerging market exposure to weather any economic "storms".
Matt Rubin, CIO, Neuberger Berman Trust says that some U.S. earnings this season will surprise to the upside, with corporate balance sheets looking good.
Ian Bremmer, president of the Eurasia Group, explains how the suppression of access to information in China impacts markets and investors.
CNBC's Sharon Epperson discusses the day's activity in the commodities markets and looks at where oil and precious metals are likely headed tomorrow.
Why 2013 could be another year of solid market gains, with Brian Belski, BMO Capital Markets; Peter Andersen, Congress Asset Management; and CNBC's Steve Liesman & Rick Santelli.
Despite the markets seeing a down day, the S&P is hovering at five-year highs. Has the market been desensitized by all the drama in Washington? Art Steinmetz, OppenheimerFunds, weighs in.
Disagreements over economic forecasts and the timing of improvement in the labor market are something the market can price in. But the investors are much more puzzled over how to deal with the split at the Fed over the balance sheet.
European stocks are sliding despite big gains for banks, with CNBC's Simon Hobbs.
CNBC's Gary Kaminsky and Mark Boyar, Boyar Asset Management president, review the performance of the "Forgotten Forty" list, which outperformed the S&P 500 last year.
Arthur Cashin, UBS provides a preview of the upcoming earnings season; and weighs in on whether the market "can stand on its own."
Thomas Lee, JPMorgan chief U.S. equity strategist, provides his perspective on where he sees the S&P headed in the coming months.
The "Squawk on the Street" news crew report on all the market moving stories of the day. Among the stories: a look at the battle on Capitol Hill over the debt ceiling; the outlook on earnings; and the Basel Committee relaxing liquidity standards for banks.
The U.S. stock market's rally to five year highs is not a "sugar-high" from the Fed but a result of a strengthening economy, market-watchers told CNBC.
CNBC's Rick Santelli and Steve Liesman provide a check on today's market activity. Also, Scott Nations, NationsShares president and CEO, takes a look at the dramatic drop in the VIX last week.